Moderna COVID-19 Vaccine Peer-Reviewed Report Released
[ad_1] Press release Wednesday, December 30, 2020 Data from the phase 3 clinical trial confirm that the vaccine is effective. What The investigational vaccine known as mRNA-1273 was 94.1% effective in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. … Read more